A citation-based method for searching scientific literature

Su-Jin Kim, Cuilan Nian, Doris J Doudet, Christopher H S McIntosh. Diabetes 2009
Times Cited: 76



Roger Yazbeck, Gordon S Howarth, Catherine A Abbott. Trends Pharmacol Sci 2009
Times Cited: 182




List of shared articles



Times cited

Effects of short-term sitagliptin treatment on immune parameters in healthy individuals, a randomized placebo-controlled study.
J D Price, G Linder, W P Li, B Zimmermann, K I Rother, R Malek, M Alattar, K V Tarbell. Clin Exp Immunol 2013
22


The pharmacokinetic considerations and adverse effects of DPP-4 inhibitors [corrected].
Theodosios D Filippatos, Vasilios G Athyros, Moses S Elisaf. Expert Opin Drug Metab Toxicol 2014
34

Dipeptidyl peptidase in autoimmune pathophysiology.
Kei Ohnuma, Osamu Hosono, Nam H Dang, Chikao Morimoto. Adv Clin Chem 2011
50

The role of incretins and incretin-based drugs in autoimmune diseases.
Shabnam Radbakhsh, Stephen L Atkin, Luis E Simental-Mendia, Amirhossein Sahebkar. Int Immunopharmacol 2021
2

Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in rats.
Toru Miyoshi, Kazufumi Nakamura, Masashi Yoshida, Daiji Miura, Hiroki Oe, Satoshi Akagi, Hiroki Sugiyama, Kaoru Akazawa, Tomoko Yonezawa, Jun Wada,[...]. Cardiovasc Diabetol 2014
49

Construction of a novel vaccine by conjugating a B-cell epitope of DPP4 to peptide IA2(5)-P2-1 to significantly control type 1 diabetes in NOD mice.
Ya Li, Huimin Cao, Yiping Li, Zhixin Li, Xiaomin Wei, Rui Jiao, Peng Cheng, Xiaoran Liu, Yanjie Ma, Yun Xing,[...]. Vaccine 2017
1

Dipeptidyl peptidase expression during experimental colitis in mice.
Roger Yazbeck, Melanie L Sulda, Gordon S Howarth, Andre Bleich, Kerstin Raber, Stephan von Hörsten, Jens Juul Holst, Catherine A Abbott. Inflamm Bowel Dis 2010
32